These results suggest a possible interaction between the CXCL12/CXCR7 and CXCL12/CXCR4 axes with consequences at the level of cancer aggressiveness, something that has also been studied in vitro in CRC and prostate cancer cells overexpressing both receptors [168]. This evidence concerns the gene CXCL12 and prostate cancer.